NCT03832127
- Conditions
- Myeloma, Neoplasms, Neoplasms by Histologic Type, +1 more
- Locations
-
- CHU d'Angers Angers, France
- CHU de Brest Brest, France
- CHU de Caen Caen, France
- CHU de Nantes Nantes, France
Clinical trial condition
Myeloma
Explore clinical trials studying Myeloma. Study availability and eligibility vary by location and protocol.
115 public trials
23 recruiting studies
Myeloma trial results
Recruiting
Bergamo Lymphoid Cancer Registry
NCT03131531
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +11 more
- Locations
-
- Hematology and Bone Marrow Transplant Unit, A.O. Ospedale Papa Giovanni XXIII Bergamo, Italy
NCT06250595
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +29 more
- Locations
-
- María del Mar Barcelona, Catalonia, Spain
Not yet recruiting
REal World MAIA UK OutcomEs
NCT07532473
- Conditions
- Myeloma, Neoplasms, Neoplasms by Histologic Type, +1 more
- Locations
-
- The Royal Wolverhampton NHS Trust Wolverhampton, United Kingdom
Not yet recruiting
Etenta-Isa-VRd in Newly Diagnosed High-Risk Multiple Myeloma
NCT07600151
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- University Medical Center Hamburg-Eppendorf Hamburg, Germany
Not yet recruiting
PROSpECT-PRIOR-2-CHEMO: PRIOR Dental Intervention Before Chemo to Reduce Chemotherapy Complications
NCT06450821
- Conditions
- Agranulocytosis, Cytopenia, Febrile Neutropenia, +16 more
- Locations
-
- Dental Translational & Clinical Research Unit (DenTCRU) Leeds, West Yorkshire, United Kingdom
Not yet recruiting
Dual-Energy Computed Tomography for Improving Imaging Assessment of Multiple Myeloma
NCT05353907
- Conditions
- Myeloma, Neoplasms, Neoplasms by Histologic Type, +1 more
- Locations
-
Not specified
Active, not recruiting
Study of Belantamab Mafodotin as Pre- and Post-autologous Stem Cell Transplant and Maintenance for Multiple Myeloma
NCT04680468
- Conditions
- Myeloma, Neoplasms, Neoplasms by Histologic Type, +1 more
- Locations
-
- University of Pennsylvania Philadelphia, Pennsylvania, United States
Active, not recruiting
Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy
NCT00871013
- Conditions
- Myeloma, Neoplasms, Neoplasms by Histologic Type, +1 more
- Locations
-
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
Active, not recruiting
Multicenter Phase 2 Study of Subcutaneous Isatuximab Plus Bortezomib, Lenalidomide and Dexamethasone in the Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma
NCT05889221
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- CHU Poitiers Poitiers, France